An Experimentally Validated Structure-Based Virtual Screening Approach to Identify Nucleotide-Binding Protein Inhibitors as a New Source of Kinase Inhibitors.

Bosc N, Carles F, Fogha J, Baratte B, Bach S, Aci-Sèche S, Bourg S, Routier S, Ruchaud S, Buron F, Bonnet P

Open source

DOI
10.3390/ph19081138
Published
2026 Jul 23
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19081138,
  title = {An Experimentally Validated Structure-Based Virtual Screening Approach to Identify Nucleotide-Binding Protein Inhibitors as a New Source of Kinase Inhibitors.},
  author = {Bosc N and Carles F and Fogha J and Baratte B and Bach S and Aci-Sèche S and Bourg S and Routier S and Ruchaud S and Buron F and Bonnet P},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19081138},
  url = {https://doi.org/10.3390/ph19081138}
}

RIS

TY  - JOUR
TI  - An Experimentally Validated Structure-Based Virtual Screening Approach to Identify Nucleotide-Binding Protein Inhibitors as a New Source of Kinase Inhibitors.
AU  - Bosc N
AU  - Carles F
AU  - Fogha J
AU  - Baratte B
AU  - Bach S
AU  - Aci-Sèche S
AU  - Bourg S
AU  - Routier S
AU  - Ruchaud S
AU  - Buron F
AU  - Bonnet P
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19081138
UR  - https://doi.org/10.3390/ph19081138
ER  - 

APA

N, B., F, C., J, F., B, B., S, B., S, A., S, B., S, R., S, R., F, B., & P, B. (2026). An Experimentally Validated Structure-Based Virtual Screening Approach to Identify Nucleotide-Binding Protein Inhibitors as a New Source of Kinase Inhibitors.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19081138

Source records